Is LTR Pharma Limited overvalued?

LTR Pharma Limited (LTP.AX) — key valuation metrics and fundamentals.

No verdict

Price

$0.44

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$80.2M

Dividend yield

—

Return on equity

—

Sector

Healthcare

Fair value compares LTP.AX's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks